Other substances

6-Carbamimidoyl-4-(3-hydroxy-2-methyl-benzoylamino)-naphthalene-2-carboxylic acid methyl ester

A factor XI inhibitor.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Experimental

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

6-Carbamimidoyl-4-(3-hydroxy-2-methyl-benzoylamino)-naphthalene-2-carboxylic acid methyl ester on PubChem

Synonyms

DB07074

 

Structure image - 6-Carbamimidoyl-4-(3-hydroxy-2-methyl-benzoylamino)-naphthalene-2-carboxylic acid methyl ester

CC1=C(C=CC=C1O)C(=O)NC2=C3C=C(C=CC3=CC(=C2)C(=O)OC)C(=N)N

Supporting references

Link Tested on Impact factor Notes Publication date
Structural Insights into the Binding Modes of Viral RNA-Dependent RNA Polymerases Using a Function-Site Interaction Fingerprint Method for RNA Virus Drug Discovery
RdRpol Small molecule In silico 		in silico 4.07

Predicted to inhibit the SARS-CoV-2 RNA-dependent RNA polymerase via subpocket 2 binding.

 Sep/18/2020
Export (.csv)